PD-1H was another p53 target overexpressed in iASPP-deficient tumor cells as well as responding lymphocytes, suggesting that iASPP might inhibit p53 transcriptional activation of PD-1H and its subsequent juxtacrine signaling [17]. This evidence concerns the gene TP53 and neoplasm.